Clinical significance of tumor necrosis factor-a-863 C/A and -1031 T/C promoter polymorphisms in systemic lupus erythematosus patients: Relation to disease activity and damage | hussein dakrony

Clinical significance of tumor necrosis factor-a-863 C/A and -1031 T/C promoter polymorphisms in systemic lupus erythematosus patients: Relation to disease activity and damage

Citation:: El-Dakrony, A. - H. M., I. El-Gazzar, S. Sayed, W. Sadek, H. El-Fishawy, and O. Shaker, "Clinical significance of tumor necrosis factor-a-863 C/A and -1031 T/C promoter polymorphisms in systemic lupus erythematosus patients: Relation to disease activity and damage", The Egyptian Rheumatologist, vol. Accepted 30 April 2017, pp. article in press, 2017.